Covered recipient · General Payments record
NATHAN QUADERER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,845.20
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $355.09 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.13 | 2 |
| Novo Nordisk AS | $63.78 | 4 |
| Amgen Inc. | $36.67 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.01 | 1 |
| PFIZER INC. | $21.71 | 1 |
| GlaxoSmithKline, LLC. | $20.01 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.67 | 1 |
| Indivior Inc. | $18.85 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $113.62 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105333165 | CMS |
| ABBVIE INC. | $23.51 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105333169 | CMS |
| Amgen Inc. | $19.86 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660174 | CMS |
| Amgen Inc. | $16.81 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660176 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.01 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118145668 | CMS |
| GlaxoSmithKline, LLC. | $20.01 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115885936 | CMS |
| Indivior Inc. | $18.85 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144535955 | CMS |
| Novo Nordisk Inc | $14.48 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918868 | CMS |
| Novo Nordisk Inc | $18.21 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097549855 | CMS |
| Novo Nordisk Inc | $15.60 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096882036 | CMS |
| Novo Nordisk Inc | $15.49 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096601493 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.67 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118964665 | CMS |
| PFIZER INC. | $21.71 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131981453 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151112648 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.